Company / Return on Equity (ROE)
Zimmer Biomet Return on Equity (ROE) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
5.5%
FY2025
5-year range
1.9% / 8.2%
FY2021-FY2025
Trend
-23.4%
vs FY2024
Sector context
#65 of 148
Health Care
What the data says
At 5.5%, Zimmer Biomet's return on equity (roe) ranks #65 of 148 in the Health Care sector. Return on Equity (ROE) has fluctuated over the past 10 years, ranging from -1.1% in FY2020 to 15.5% in FY2017.
Based on SEC 10-K filings.
5.5% in FY2025 with a 5-year CAGR of +6.7%.
Declined from 8.2% to 5.5% over the past 2 years.
Health Care sector context is included.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- +3.6pp
- 5-Year Change
- +6.7pp
- 10-Year Change
- -
Sector benchmark
#65 of 148 in Health CareTop 44% of 148This company 5.5% Sector average -3.2%
▼
+271.3% above sector average
Key checks
Key Insights
- In FY2025, return on equity (roe) decreased 23.4% year-over-year.
- Currently 8.8pp above the Health Care sector average.
- Peak return on equity (roe) was recorded in FY2017.
- Lowest return on equity (roe) in the period was in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 5.5% | -23.4% |
| FY2024 | 7.2% | -11.6% |
| FY2023 | 8.2% | +324.9% |
| FY2022 | 1.9% | -39.1% |
| FY2021 | 3.2% | +378.1% |
| FY2020 | -1.1% | -107.8% |
| FY2019 | 14.6% | +440.2% |
| FY2018 | 2.7% | -82.5% |
| FY2017 | 15.5% | +107.5% |
| FY2016 | 7.4% | +400.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026